Insulin resistance is central to the pathogenesis of Type II diabetes (NIDDM), and is largely due to decreased activity of the glucose transport system in target tissue. However, the mechanisms responsible for reduced transport activity are unknown. In pre- liminary studies, we found both cellular depletion and impaired function of glucose transport proteins causing insulin resistance in adipocytes isolated from these patients. Therefore, in the current proposal, we will extensively examine the role of glucose transporters in the cellular insulin resistance of NIDDM, by measuring their number, structure, function, and regulation in target tissue. In adipocytes from control and NIDDM subjects, we will use both cytochalasin B binding and immunologic methods to measure the number and cellular distribution of transporters under basal conditions as well as insulin's ability to recruit intracellular carriers to the cell-surface. Function will be assessed by correlating numbers of cell-surface transporters with glucose transport rates in intact cells, and by correlating glucose transporter number and functional activity of transporters isolated from various subcellular and membrane fractions and then reconstituted into synthetic phospholipid vesicles. The Km and Vmax of substrate uptake will also be measured in whole cells since defects in these functional parameters have mechanistic implications. To test for structural abnormalities, we will combine SDS-PAGE and isoelectric focusing to determine the MW, charge heterogeneity, and extent of post-translational glycosylation of photolabeled transporters, as well as measure the non-enzymatic glycosylation of transporters using an antibody specific for glycosyl-lysine adducts. In other studies, we will try to delineate those regulatory events which impair transporter number and function in NIDDM. To determine whether transporter number is regulated at the transcriptional level, we will measure the amount of transporter mRNA in adipocytes and muscle on Northern blots using a hybridizing cDNA probe. We will also test the hypothesis that high concentrations of glucose and insulin regulate transporter number, structure, function, and mRNA levels in vitro using our primary culture method for adipocytes, and in vivo before and after a period of euglycemic therapy. Finally, we will pursue a collaborative project to raise site-specific antibodies against the transporter. Hopefully, these studies will delineate the role of glucose transporters in the mechanism and pathogenesis of insulin resistance in NIDDM, and suggest improved therapeutic strategies.

Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Steverson Jr, Dennis; Tian, Ling; Fu, Yuchang et al. (2016) Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation. Metab Syndr Relat Disord 14:7-15
Guo, Fangjian; Garvey, W Timothy (2016) Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults. Obesity (Silver Spring) 24:516-25
Guo, Fangjian; Garvey, W Timothy (2015) Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes. J Clin Endocrinol Metab 100:3871-7
Garvey, W Timothy (2015) The conundrum of whole foods versus macronutrient composition in assessing effects on insulin sensitivity. Am J Clin Nutr 101:1109-10
Grams, J; Garvey, W Timothy (2015) Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep 4:287-302
Thalacker-Mercer, Anna E; Ingram, Katherine H; Guo, Fangjian et al. (2014) BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes 63:791-800
Guo, Fangjian; Moellering, Douglas R; Garvey, W Timothy (2014) Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord 12:258-68
Guo, Fangjian; Moellering, Douglas R; Garvey, W Timothy (2014) The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring) 22:110-8
Hill, H S; Grams, J; Walton, R G et al. (2014) Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res 46:341-7
Daniel, Sunil; Soleymani, Taraneh; Garvey, W Timothy (2013) A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes 20:377-88

Showing the most recent 10 out of 18 publications